Reception of Slit requires only the chondroitin–sulphate-modified extracellular domain of Syndecan at the target cell surface

  1. Bhavna Chanana,
  2. Patrick Steigemann,1,
  3. Herbert Jäckle and
  4. Gerd Vorbrüggen,2
  1. Max-Planck-Institut für biophysikalische Chemie, Abteilung Molekulare Entwicklungsbiologie, Am Fassberg 11, 37077 Göttingen, Germany

Abstract

Syndecan (Sdc) is a conserved transmembrane heparan sulfate proteoglycan (HSPG) bearing additional chondroitin sulfate (CS) modifications on its extracellular domain. In vertebrates, this extracellular domain of Sdc is shed and acts as a soluble effector of cellular communication events, and its cytoplasmic domain participates in intracellular signaling needed to maintain epithelial integrity. In Drosophila, Sdc has been shown to be necessary for Slit signaling-dependent axon and myotube guidance during CNS development and muscle pattern formation. We report that Sdc acts in a cell-autonomous manner in Slit-receiving cells and that its membrane-anchored extracellular domain is sufficient to mediate Slit signaling. Sdc activity can be replaced by the human homolog hsdc2. However, the HSPG Dally-like protein (Dlp), which lacks CS modifications at its extracellular domain, can only partially substitute for Sdc function, and its activity is not restricted to the Slit target cells. Our results suggest that Sdc and Dlp act in a cooperative but nonredundant fashion in axon and myotube guidance. We propose that Dlp, which lacks CS modifications, participates in the transfer of Slit from its site of expression to the target cells, where CS-modified Sdc concentrates and presents the ligand.

Footnotes

  • 2To whom correspondence should be addressed. E-mail: gvorbru{at}gwdg.de
  • Edited by Walter J. Gehring, University of Basel, Basel, Switzerland, and approved May 20, 2009

  • Author contributions: B.C., H.J., and G.V. designed research; B.C., P.S., and G.V. performed research; B.C., P.S., and G.V. analyzed data; and B.C., H.J., and G.V. wrote the paper.

  • 1Present address: Eidgenössische Technische Hochschule, Institut für Biochemie, Schafmattstrasse 18, CH-8093 Zürich, Switzerland.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/cgi/content/full/0901148106/DCSupplemental.

« Previous | Next Article »Table of Contents